Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Grupo Cooperativo para el Cribado del Cancer Colorrectal en España.

Gastrointestinal Oncology Group of the Spanish Gastroenterological Association

Fundacion Cientifica de la Asociacion Española contra el Cancer

Instituto de Salud Carlos III

Information provided by:

Hospital Clinic of Barcelona

ClinicalTrials.gov Identifier:

NCT00906997

First received: May 19, 2009

Last updated: June 21, 2011

Last verified: June 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	November 2021
Estimated Primary Completion Date:	November 2021 (Final data collection date for primary outcome measure)

No publications provided by Hospital Clinic of Barcelona

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A; COLONPREV Study Investigators. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012 Feb 23;366(8):697-706.

To Top